The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the microb1
A study conducted at Hospital Clínic analysed the genetic profile of more than 300 patients with solid tumours using a liquid biopsy blood test, resu1
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1
The researcher has received a runner’s-up prize in the Dr. Font Prize category, which recognises the best research articles published, with potential1
Mediterranean diet or mindfulness-based stress reduction interventions during pregnancy reduce the prevalence of low birth weight by 29-36% as well a1
On Friday, 26 November, the dissemination seminar \"Immunotherapy 2.0 in lymphoma: how to design personalized therapies\" for patients and relatives1
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit
The Hospital Clínic-IDIBAPS researcher has been awarded in the basic research category.
On Tuesday 16 November and Wednesday 17 November, school-leaving students and students in higher education took part in the open-air science workshop1
The biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to sta1